Bristlecone Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-17,124
Closed -$1.08M 198
2020
Q3
$1.08M Sell
17,124
-7,002
-29% -$486K 0.2% 101
2020
Q2
$1.86M Buy
24,126
+15,741
+188% +$1.21M 0.38% 70
2020
Q1
$627K Buy
8,385
+65
+0.8% +$4.49K 0.15% 111
2019
Q4
$541K Buy
8,320
+305
+4% +$19.9K 0.11% 131
2019
Q3
$508K Sell
8,015
-3,579
-31% -$234K 0.12% 111
2019
Q2
$783K Sell
11,594
-13,752
-54% -$905K 0.19% 97
2019
Q1
$1.65M Sell
25,346
-665
-3% -$44.2K 0.46% 64
2018
Q4
$1.63M Sell
26,011
-25
-0.1% -$1.75K 0.49% 68
2018
Q3
$2.01M Buy
26,036
+11,741
+82% +$887K 0.51% 58
2018
Q2
$1.01M Sell
14,295
-4,418
-24% -$312K 0.34% 73
2018
Q1
$1.41M Sell
18,713
-6,732
-26% -$535K 0.47% 56
2017
Q4
$1.82M Sell
25,445
-1,085
-4% -$82.4K 0.58% 50
2017
Q3
$2.15M Sell
26,530
-25
-0.1% -$1.91K 0.7% 42
2017
Q2
$1.88M Sell
26,555
-345
-1% -$23K 0.64% 51
2017
Q1
$1.83M Sell
26,900
-760
-3% -$53.4K 0.64% 49
2016
Q4
$1.98M Buy
27,660
+2,570
+10% +$191K 0.71% 46
2016
Q3
$1.99M Buy
+25,090
New +$2.04M 0.72% 45
2016
Q2
Sell
-24,787
Closed -$2.28M 144
2016
Q1
$2.28M Buy
24,787
+1,300
+6% +$117K 0.9% 33
2015
Q4
$2.38M Buy
+23,487
New +$2.44M 1% 23

Other funds holding GILD

Bristlecone Advisors's GILD Position: Q4 2020 in Review

Bristlecone Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 17,124 shares — an estimated $1.08M sold.

Bristlecone Advisors first reported a position in GILD in Q4 2015 and held it in 19 quarters. The position peaked at $2.38M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Bristlecone Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Bristlecone Advisors sold 17,124 Gilead Sciences shares in Q4 2020, an estimated $1.08M.
  • Bristlecone Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 19 quarters.
  • Bristlecone Advisors's Gilead Sciences position peaked at $2.38M in Q4 2015.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Bristlecone Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.